Koninklijke Philips (PHG) Gains from Investment Securities (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Gains from Investment Securities of -$108.1 million for Q2 2026, down 9649.78% year-over-year from $1.1 million in Q2 2025, and down 810.26% quarter-over-quarter from $15.2 million in Q1 2026.
Koninklijke Philips (PHG) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Koninklijke Philips' Gains from Investment Securities history runs 17 years deep, the most recent figure standing at -$108.1 million for Q2 2026.
- In Q2 2026, Gains from Investment Securities fell 9649.78% year-over-year to -$108.1 million; the TTM figure through Jun 2026 stood at -$65.0 million (down 226.23% YoY), while the FY2025 annual figure was $26.8 million, up 231.87% from the prior year.
- Gains from Investment Securities for Q2 2026 stood at -$108.1 million, down from $15.2 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $30.3 million in Q4 2025, with the low at -$117.3 million in Q4 2022.
- The 5-year median for Gains from Investment Securities is -$2.2 million (2025), against an average of -$21.7 million.
- Peak annual rise in Gains from Investment Securities reached 823.45% in 2026, while the deepest fall reached 9649.78% in 2026.
- Koninklijke Philips' Gains from Investment Securities stood at -$117.3 million in 2022, then surged by 34.89% to -$76.4 million in 2023, then surged by 60.83% to -$29.9 million in 2024, then jumped by 201.15% to $30.3 million in 2025, then plunged by 457.18% to -$108.1 million in 2026.
- Business Quant data shows PHG's Gains from Investment Securities at -$108.1 million in Q2 2026, $15.2 million in Q1 2026, and $30.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -108.10 Mn |
| Jun 30, 2026 | -108.10 Mn |
| Mar 31, 2026 | 15.22 Mn |
| Mar 31, 2026 | 15.22 Mn |
| Dec 31, 2025 | 30.27 Mn |
| Dec 31, 2025 | 30.27 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | -2.10 Mn |
| Mar 31, 2025 | -2.10 Mn |
| Dec 31, 2024 | -29.92 Mn |
| Dec 31, 2024 | -29.92 Mn |
| Sep 30, 2024 | 10.98 Mn |
| Sep 30, 2024 | 10.98 Mn |
| Jun 30, 2024 | -1.08 Mn |
| Jun 30, 2024 | -1.08 Mn |
| Mar 31, 2024 | -1.09 Mn |
| Mar 31, 2024 | -1.09 Mn |